sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
COVID-19 Outbreak-Global Oncology Biosimilars Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

COVID-19 Outbreak-Global Oncology Biosimilars Industry Market Report-Development Trends, Threats, Opportunities...

Home / Categories / Healthcare
COVID-19 Outbreak-Global Oncology Biosimilars Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
COVID-19 Outbreak-Global Oncology Biosimilars Industry...
Report Code
RO1/125/7789

Publish Date
19/Jan/2021

Pages
115
PRICE
$ 3660/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5490/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7320/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Oncology Biosimilars are kind of Biosimilars. A biosimilar product is a biologic agent that is highly similar to an already-approved biological compound, known as the reference or originator product, and approved for use in the same indications as the reference product
The Oncology Biosimilars market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Oncology Biosimilars industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Oncology Biosimilars market can be split based on product types, major applications, and important countries as follows:

Key players in the global Oncology Biosimilars market covered in Chapter 12:
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd.
Sandoz International GmbH
Amgen Biosimilars
Samsung Bioepis Co. Ltd.
Celltrion Inc.
Pfizer, Inc.
Intas Pharmaceuticals Ltd.

In Chapter 4 and 14.1, on the basis of types, the Oncology Biosimilars market from 2015 to 2025 is primarily split into:
G-CSF
Hematopoietic Agents
Monoclonal Antibodies

In Chapter 5 and 14.2, on the basis of applications, the Oncology Biosimilars market from 2015 to 2025 covers:
Retail pharmacies
Hospital pharmacies
Online pharmacies

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com